- Emerging markets have been suffering from the global tightening of financial conditions (rising US yield and dollar)
- At this stage, the sell-off remains differentiated and the impact on growth is manageable
- Buyoant US growth and inflation at target confirm quarterly Fed hiking pace until mid-2019; other main central banks have also confirmed their gradual monetary normalisation trajectory
- We maintain our asset allocation, with an overweight US and emerging market equities vs. an underweight euro fixed income
The return of US dollar pain
Five years ago1, Professor Hélène Rey reminded central bankers gathered at Jackson Hole, of how the close interconnection of capital markets represented a facilitator in the transmission of shocks, initiated at the global centre of monetary policy, the US Federal Reserve (Fed). The tightening of global financial conditions, id est the rise in US yields and the appreciation of the US dollar, is therefore the most obvious trigger behind the recent emerging market (EM) sell-off. However US-led protectionism, which risks disrupting the global supply chain, as well as worries of China’s internal demand slowing down faster than expected – and a collection of other idiosyncratic stories – clearly did not help EMs either.
 Rey, H., “Dilemma not Trilemma: The Global Financial Cycle and Monetary Policy Independence”, NBER, last revised in Feb 2018
1 Rey, H., “Dilemma not Trilemma: The Global Financial Cycle and Monetary Policy Independence”, NBER, last revised in Feb 2018
This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.
It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date. All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document. Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.
This document has been edited by AXA INVESTMENT MANAGERS SA, a company incorporated under the laws of France, having its registered office located at Tour Majunga, 6 place de la Pyramide, 92800 Puteaux, registered with the Nanterre Trade and Companies Register under number 393 051 826. In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.
In the UK, this document is intended exclusively for professional investors, as defined in Annex II to the Markets in Financial Instruments Directive 2014/65/EU (“MiFID”). Circulation must be restricted accordingly.
© AXA Investment Managers 2018. All rights reserved